The largest database of trusted experimental protocols

Plvx tre3g ires

Manufactured by Takara Bio
Sourced in United States

The PLVX-TRE3G-IRES is a lentiviral transfer vector designed for inducible gene expression. It contains the Tet-responsive element (TRE) promoter, which allows for tight regulation of gene expression in the presence of tetracycline or its derivatives. The vector also includes an internal ribosome entry site (IRES) for bicistronic expression of the gene of interest and a reporter gene.

Automatically generated - may contain errors

6 protocols using plvx tre3g ires

1

Ikaros Isoforms Regulate Pre-B ALL Cell Fate

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient-derived, xenograft-expanded human BCR-ABL1+ pre–B ALL cells were cultured in vitro with or without irradiated OP9 cells as stromal support. Human full-length WT Ikaros (IK1) and the leukemia-derived DN IK6 isoform created by Rag-mediated intragenic deletion (Mullighan et al., 2008 (link)), were cloned from above patient-derived pre–B ALL cells and verified by Sanger sequencing. The two Ikaros isoforms and GFP were cloned into the TET-inducible expression vector pLVX-TRE3G-IRES (Takara Bio Inc.) with In-Fusion cloning reagents (Takara Bio Inc.). Lentiviral supernatants for expression of pLVX-EF1a-Tet3G (Takara Bio Inc.) and aforementioned cloned Ikaros and GFP-control pLVX-TRE3G-IRES were produced with the packaging vector pCDNLBH and EM140 envelope vector. Expression was induced with doxycycline, a tetracycline (TET) analogue. For Cas9/CRISPR-mediated depletion experiments, scrambled or gene-targeting gRNA sequences (Table S5) were purchased from Transomic technologies (cloned into the pCLIP-grNA-hCMV-RFP vector) and transduced into parental cells that had been stably transduced and selected for DOX-inducible expression of Cas9-IRES-ZsGreen.
+ Open protocol
+ Expand
2

Inducible Ik1 Isoform Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cloning and cell line generation was performed as described previously [29 (link)]. Briefly, full length Ikaros isoform (Ik1) with IRES-GFP and an empty vector IRES-GFP control were cloned into the TET-inducible expression vector pLVX-TRE3G-IRES (Takara Bio, San Jose, CA, USA) and transduced into B-ALL cells expressing TET activator pLVX-EF1a-Tet3G (Takara Bio, San Jose, CA, USA). Expression of wild-type IK1 and GFP control samples was induced with the addition of 1 ug/mL doxycycline, a TET analog.
+ Open protocol
+ Expand
3

Lentiviral Transduction of ERG Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
For transfection-based reporter assays, human GR and MR were cloned into pACT (Promega) as N-terminal VP16 fusions using HiFi assembly (NEB). The human ERG ETS domain, and human VP16-AR WT and mutants were cloned into pCDNA3.1 using HiFi assembly. All other constructs were described previously (Wasmuth et al., 2020 (link)). For lentiviral transduction of ERG variants in mouse prostate organoids, modified derivatives of pLVX-TRE3G-IRES (Takara) were engineered for constitutive expression by replacing the TRE3G element with a UBC promoter. To construct LVX-eGFP-ERG-PuroR variants, eGFP was cloned into MCS I; human ERG variants were cloned via HiFi assembly into MCS II.
+ Open protocol
+ Expand
4

Lentiviral Transduction of ERG Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
For transfection-based reporter assays, human GR and MR were cloned into pACT (Promega) as N-terminal VP16 fusions using HiFi assembly (NEB). The human ERG ETS domain, and human VP16-AR WT and mutants were cloned into pCDNA3.1 using HiFi assembly. All other constructs were described previously (Wasmuth et al., 2020 (link)). For lentiviral transduction of ERG variants in mouse prostate organoids, modified derivatives of pLVX-TRE3G-IRES (Takara) were engineered for constitutive expression by replacing the TRE3G element with a UBC promoter. To construct LVX-eGFP-ERG-PuroR variants, eGFP was cloned into MCS I; human ERG variants were cloned via HiFi assembly into MCS II.
+ Open protocol
+ Expand
5

Inducible Expression of Cdc42 in Glioma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Tet-On® 3G Inducible Expression System containing pLVX-TRE3G-IRES and pLVX-Tet3G vectors was purchased from Clontech (Mountain view, CA). The Cdc42 construct (pCMVXL5-Cdc42) was generated by SIDNET at The Hospital for Sick Children. Briefly, the Cdc42 open reading frame was cloned into the pLVX-Tet3G vector via BamHI and NotI sites and packaged into lentiviruses [50 (link)]. Cells infected with viruses were selected in medium containing puromycin at 0.4 μg/ml for U87MG and U251MG. Doxycycline (Sigma-Aldrich) at 500ng/ml was used to induce Cdc42 expression in cell culture. Cdc42 activation assay and western blot analysis were performed to verify the construct expression level.
+ Open protocol
+ Expand
6

Establishment of Inducible Gene Expression in hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ORF sequence of ENSG00000205704 and the human codon-optimized HA × 3 sequence were cloned into pLVX-TRE3G-IRES (Clontech, 631362), which was subjected to the production of the lentivirus stock. For transduction, concentrated viruses were added into the hPSC medium (MOI 10) and incubated with polybrene (Sigma, 8 μg ml−1) and Y-27632 (10 ng ml−1) for 24 h. The virus packaged with pLVX-EF1a-Tet3G constructs (Clontech, 631359) were also co-tranducted into hESCs to built the Tet-on system. After selection with G418 (Sigma, 400 μg ml−1) and puromicin (Sigma, 0.5 μg ml−1) for 2 weeks, individual colonies were picked and further genotyped with real-time PCR assays under 2 days of doxorubicin (Sigma, 1 μg ml−1) treatment (primers: ORF-RT-F and ORF-RT-R).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!